HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
140536.0,253109,2183-01-08 06:15:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 72yo M p/w +biomarkers in the setting of LLL PNA due
   to demand ischemia vs NSTEMI.  Hypovolemia vs septic picture.
   24 Hour Events:
 INVASIVE VENTILATION - START [**2183-1-7**] 06:24 PM
 MULTI LUMEN - START [**2183-1-7**] 06:51 PM
 ARTERIAL LINE - START [**2183-1-7**] 10:04 PM
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 600 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 06:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 41 (37 - 54) bpm
   BP: 113/60(77) {102/57(76) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 14 (14 - 14)mmHg
   Total In:
                                                                    638 mL
                                                                  1,028 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,028 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    280 mL
   Urine:
                                                                    125 mL
                                                                    280 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    748 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 945 (945 - 945) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 9
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 13
   PIP: 11 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 8.1 L/min
   PaO2 / FiO2: 332
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : ), coarse breath sounds
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Musculoskeletal: No(t) Muscle wasting
   Skin:  Warm, Rash: diffuse
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Fluid analysis / Other labs: UA pending
   Imaging: CXR: wetread: ETT tip 4.5c from carina, NGH & sidehole over
   stomach R PICC tip mid SVC, Low lung vol Retrocardic opacities
   Microbiology: Sputum culture pending
   Urine culture pending
   Blood culture x3 pending
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - CXR in AM, f/u on final
   - consider urine legionella ag
   - RSBI today, consider extubation if doing well, stop fentanyl and
   midazolam this AM
   - wean vent settings
   - f/u sputum cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition: NPO
   Glycemic Control:  ISS
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: Heparin gtt
   Stress ulcer: famotidine
   VAP:  abx
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 72yo M p/w +biomarkers in the setting of LLL PNA due
   to demand ischemia vs NSTEMI.  Hypovolemia vs septic picture.
   24 Hour Events:
 INVASIVE VENTILATION - START [**2183-1-7**] 06:24 PM
 MULTI LUMEN - START [**2183-1-7**] 06:51 PM
 ARTERIAL LINE - START [**2183-1-7**] 10:04 PM
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 600 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 06:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 41 (37 - 54) bpm
   BP: 113/60(77) {102/57(76) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 14 (14 - 14)mmHg
   Total In:
                                                                    638 mL
                                                                  1,028 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,028 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    280 mL
   Urine:
                                                                    125 mL
                                                                    280 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    748 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 945 (945 - 945) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 9
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 13
   PIP: 11 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 8.1 L/min
   PaO2 / FiO2: 332
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : ), coarse breath sounds
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Musculoskeletal: No(t) Muscle wasting
   Skin:  Warm, Rash: diffuse
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Fluid analysis / Other labs: UA pending
   Imaging: CXR: wetread: ETT tip 4.5c from carina, NGH & sidehole over
   stomach R PICC tip mid SVC, Low lung vol Retrocardic opacities
   Microbiology: Sputum culture pending
   Urine culture pending
   Blood culture x3 pending
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - CXR in AM, f/u on final
   - consider urine legionella ag
   - RSBI today, consider extubation if doing well, stop fentanyl and
   midazolam this AM
   - wean vent settings
   - f/u sputum cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition: NPO
   Glycemic Control:  ISS
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: Heparin gtt
   Stress ulcer: famotidine
   VAP:  abx
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 72-year-old male admitted to the ICU with pneumonia due to demand ischemia vs NSTEMI, hypovolemia, and septic picture. He has a history of COPD, Afib, and hyperlipidemia. His current vital signs are: temperature 96.8Â°C, heart rate 41 bpm, blood pressure 113/60 mmHg, respiratory rate 9 breaths per minute, and oxygen saturation 100%. He is receiving invasive ventilation, multi-lumen catheters, and arterial line. His lab results show elevated troponin, mildly elevated CK-MB, and abnormal liver function tests.

Potential medical complications:

1. Respiratory failure: The patient's respiratory status is unstable, and he is requiring invasive ventilation. He has a risk of developing further respiratory failure, including pneumonia and ventilator-associated pneumonia.
2. Cardiac complications: The patient has elevated troponin and mildly elevated CK-MB, indicating possible acute myocardial injury. He has a history of demand ischemia vs NSTEMI, and his cardiac status is uncertain.
3. Sepsis: The patient's septic picture is concerning, and he may develop further complications, including organ failure and death.
4. Pneumonia: The patient has pneumonia, and there is a risk of developing further complications, including respiratory failure and death.
5. Hypovolemia: The patient is hypovolemic, and there is a risk of developing further complications, including hypotension and organ failure.
6. Hyperglycemia: The patient has hyperglycemia, and there is a risk of developing further complications, including ketoacidosis and hyperosmolar nonketotic syndrome.
7. Rash: The patient has a rash, and it may be related to a drug reaction or an underlying condition such as lichen planus or toxic epidermal necrosis.
8. Hyponatremia: The patient has hyponatremia, and it may be related to volume loss or SIADH.
9. Hypotension: The patient has hypotension, and it may be related to septic shock or hypovolemia.
10. Glaucoma: The patient has glaucoma, and there is a risk of developing further complications, including vision loss and blindness.

Recommendations:

1. Continue to monitor the patient's respiratory status and adjust ventilation settings as necessary.
2. Continue to monitor the patient's cardiac status and adjust treatment as necessary.
3. Continue to treat the patient's septic picture with antibiotics and fluids as necessary.
4. Continue to monitor the patient's pneumonia and adjust treatment as necessary.
5. Continue to monitor the patient's hypovolemia and adjust treatment as necessary.
6. Continue to monitor the patient's hyperglycemia and adjust treatment as necessary.
7. Continue to monitor the patient's rash and adjust treatment as necessary.
8. Continue to monitor the patient's hyponatremia and adjust treatment as necessary.
9. Continue to monitor the patient's hypotension and adjust treatment as necessary.
10. Continue to monitor the patient's glaucoma and adjust treatment as necessary."
140536.0,253109,2183-01-08 06:15:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 72yo M p/w +biomarkers in the setting of LLL PNA due
   to demand ischemia vs NSTEMI.  Hypovolemia vs septic picture.
   24 Hour Events:
 INVASIVE VENTILATION - START [**2183-1-7**] 06:24 PM
 MULTI LUMEN - START [**2183-1-7**] 06:51 PM
 ARTERIAL LINE - START [**2183-1-7**] 10:04 PM
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 600 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 06:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 41 (37 - 54) bpm
   BP: 113/60(77) {102/57(76) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 14 (14 - 14)mmHg
   Total In:
                                                                    638 mL
                                                                  1,028 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,028 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    280 mL
   Urine:
                                                                    125 mL
                                                                    280 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    748 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 945 (945 - 945) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 9
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 13
   PIP: 11 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 8.1 L/min
   PaO2 / FiO2: 332
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : ), coarse breath sounds
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Musculoskeletal: No(t) Muscle wasting
   Skin:  Warm, Rash: diffuse
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Fluid analysis / Other labs: UA pending
   Imaging: CXR: wetread: ETT tip 4.5c from carina, NGH & sidehole over
   stomach R PICC tip mid SVC, Low lung vol Retrocardic opacities
   Microbiology: Sputum culture pending
   Urine culture pending
   Blood culture x3 pending
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - CXR in AM, f/u on final
   # Respiratory distress [**12-31**] PNA, lung disease.  LLL PNA at OSH.  Given
   recent hospitalization in [**October 2182**] we will give vancomycin/cefepime
   instead of azithromycin/ceftriaxone he received at OSH for HCAP.  LFTs
   nml at OSH.
   -Vanc/Cefepime, Vanc trough after 3 doses
   -CXR in AM
   -Continue intubation w/ fentanyl and midalozam.
   -Wean FiO2 as tolerated
   - f/u Sputum Cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with nebs (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 72yo M p/w +biomarkers in the setting of LLL PNA due
   to demand ischemia vs NSTEMI.  Hypovolemia vs septic picture.
   24 Hour Events:
 INVASIVE VENTILATION - START [**2183-1-7**] 06:24 PM
 MULTI LUMEN - START [**2183-1-7**] 06:51 PM
 ARTERIAL LINE - START [**2183-1-7**] 10:04 PM
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 600 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 06:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 41 (37 - 54) bpm
   BP: 113/60(77) {102/57(76) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 14 (14 - 14)mmHg
   Total In:
                                                                    638 mL
                                                                  1,028 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,028 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    280 mL
   Urine:
                                                                    125 mL
                                                                    280 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    748 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 945 (945 - 945) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 9
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 13
   PIP: 11 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 8.1 L/min
   PaO2 / FiO2: 332
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : ), coarse breath sounds
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Musculoskeletal: No(t) Muscle wasting
   Skin:  Warm, Rash: diffuse
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Fluid analysis / Other labs: UA pending
   Imaging: CXR: wetread: ETT tip 4.5c from carina, NGH & sidehole over
   stomach R PICC tip mid SVC, Low lung vol Retrocardic opacities
   Microbiology: Sputum culture pending
   Urine culture pending
   Blood culture x3 pending
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - CXR in AM, f/u on final
   # Respiratory distress [**12-31**] PNA, lung disease.  LLL PNA at OSH.  Given
   recent hospitalization in [**October 2182**] we will give vancomycin/cefepime
   instead of azithromycin/ceftriaxone he received at OSH for HCAP.  LFTs
   nml at OSH.
   -Vanc/Cefepime, Vanc trough after 3 doses
   -CXR in AM
   -Continue intubation w/ fentanyl and midalozam.
   -Wean FiO2 as tolerated
   - f/u Sputum Cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with nebs (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the progress note, the patient is a 72-year-old male who presents with positive biomarkers in the setting of pneumonia due to demand ischemia vs NSTEMI. He has been intubated and is receiving invasive ventilation, multi-lumen catheters, and arterial lines. His vital signs are stable, with a heart rate of 41 beats per minute, blood pressure of 113/60 mmHg, and oxygen saturation of 100%. His respiratory support is set to CPAP/PSV mode with a tidal volume of 650 mL, respiratory rate of 12 breaths per minute, and fraction of inspired oxygen (FiO2) of 50%.

The patient has a history of COPD, and his lung disease is exacerbating his pneumonia. He is also at risk for sepsis due to his pneumonia and possible septic picture. His cardiac status is concerning, with a new wall motion abnormality and elevated troponin levels, suggesting possible acute myocardial injury.

The patient has several potential medical complications that need to be monitored and managed:

1. Respiratory failure: The patient's pneumonia and underlying lung disease put him at risk for respiratory failure. His respiratory support is set to CPAP/PSV mode, and his FiO2 is being weaned as tolerated.
2. Sepsis: The patient's pneumonia and possible septic picture put him at risk for sepsis. His infection is being treated with vancomycin and cefepime, and he is receiving fluids as needed.
3. Cardiac complications: The patient's cardiac status is concerning, with a new wall motion abnormality and elevated troponin levels. He is being managed medically for now, and his cardiac catheterization is being deferred until his respiratory status is stable.
4. Hyponatremia: The patient's sodium level is low, which may be due to volume loss or SIADH. He is receiving 1 L of normal saline to correct his hyponatremia.
5. Rash: The patient has a rash that has been present for three months, which may be due to a drug reaction to lisinopril. He is being consulted with dermatology to determine the cause of the rash and to develop a plan for treatment.
6. Prolonged QTc: The patient's QTc interval is prolonged, which may be due to medication side effects, ischemic heart disease, or hypocalcemia. He is being monitored for signs of arrhythmia and his electrolytes are being corrected as needed.
7. Hyperglycemia: The patient's blood glucose level is elevated, which may be due to his pneumonia and underlying lung disease. He is being managed with insulin to control his blood glucose level.

Overall, the patient is at risk for several medical complications, including respiratory failure, sepsis, cardiac complications, hyponatremia, rash, prolonged QTc, and hyperglycemia. He requires close monitoring and management to prevent these complications and to improve his clinical outcome."
140536.0,253109,2183-01-08 06:15:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 72yo M p/w +biomarkers in the setting of LLL PNA due
   to demand ischemia vs NSTEMI.  Hypovolemia vs septic picture.
   24 Hour Events:
 INVASIVE VENTILATION - START [**2183-1-7**] 06:24 PM
 MULTI LUMEN - START [**2183-1-7**] 06:51 PM
 ARTERIAL LINE - START [**2183-1-7**] 10:04 PM
   Changed antibiotics
 vanc/cefepime
   [**Known lastname 13180**], [**Known firstname **]
    [**Numeric Identifier 13181**]
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 600 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 06:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 41 (37 - 54) bpm
   BP: 113/60(77) {102/57(76) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 14 (14 - 14)mmHg
   Total In:
                                                                    638 mL
                                                                  1,028 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,028 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    280 mL
   Urine:
                                                                    125 mL
                                                                    280 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    748 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 945 (945 - 945) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 9
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 13
   PIP: 11 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 8.1 L/min
   PaO2 / FiO2: 332
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : ), coarse breath sounds, intubated
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Musculoskeletal: No(t) Muscle wasting
   Skin:  Warm, Rash: diffuse
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Fluid analysis / Other labs: UA pending
   Imaging: CXR: wetread: ETT tip 4.5c from carina, NGH & sidehole over
   stomach R PICC tip mid SVC, Low lung vol Retrocardic opacities
   Microbiology: Sputum culture pending
   Urine culture pending
   Blood culture x3 pending
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH. Differential includes viral pna and
   bacterial pna. Contribution from underlying lung disease.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - check EKG, consider readding azithro to cover atypicals
   - flu DFA
   - CXR in AM, f/u on final
   - consider urine legionella ag
   - RSBI today, consider extubation if doing well, stop fentanyl and
   midazolam this AM
   - wean vent settings
   - f/u sputum cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Anemia: unclear etiology. [**Month (only) 51**] be secondary to alcoholism, viral
   pathology, hemolysis
   - consider viral etiology
   - guaiac stool
   - consider HIV test
   - consider hemolysis labs and iron studies.
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   - urine lytes
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg q4h per CIWA when extubated
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition: NPO
   Glycemic Control:  ISS
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: Heparin gtt
   Stress ulcer: famotidine
   VAP:  abx
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 72yo M p/w +biomarkers in the setting of LLL PNA due
   to demand ischemia vs NSTEMI.  Hypovolemia vs septic picture.
   24 Hour Events:
 INVASIVE VENTILATION - START [**2183-1-7**] 06:24 PM
 MULTI LUMEN - START [**2183-1-7**] 06:51 PM
 ARTERIAL LINE - START [**2183-1-7**] 10:04 PM
   Changed antibiotics
 vanc/cefepime
   [**Known lastname 13180**], [**Known firstname **]
    [**Numeric Identifier 13181**]
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 600 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 06:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 41 (37 - 54) bpm
   BP: 113/60(77) {102/57(76) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 14 (14 - 14)mmHg
   Total In:
                                                                    638 mL
                                                                  1,028 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,028 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    280 mL
   Urine:
                                                                    125 mL
                                                                    280 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    748 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 945 (945 - 945) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 9
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 13
   PIP: 11 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 8.1 L/min
   PaO2 / FiO2: 332
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : ), coarse breath sounds, intubated
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Musculoskeletal: No(t) Muscle wasting
   Skin:  Warm, Rash: diffuse
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Fluid analysis / Other labs: UA pending
   Imaging: CXR: wetread: ETT tip 4.5c from carina, NGH & sidehole over
   stomach R PICC tip mid SVC, Low lung vol Retrocardic opacities
   Microbiology: Sputum culture pending
   Urine culture pending
   Blood culture x3 pending
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH. Differential includes viral pna and
   bacterial pna. Contribution from underlying lung disease.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - check EKG, consider readding azithro to cover atypicals
   - flu DFA
   - CXR in AM, f/u on final
   - consider urine legionella ag
   - RSBI today, consider extubation if doing well, stop fentanyl and
   midazolam this AM
   - wean vent settings
   - f/u sputum cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Anemia: unclear etiology. [**Month (only) 51**] be secondary to alcoholism, viral
   pathology, hemolysis
   - consider viral etiology
   - guaiac stool
   - consider HIV test
   - consider hemolysis labs and iron studies.
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   - urine lytes
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg q4h per CIWA when extubated
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition: NPO
   Glycemic Control:  ISS
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: Heparin gtt
   Stress ulcer: famotidine
   VAP:  abx
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 72-year-old male admitted to the ICU with a diagnosis of pneumonia due to demand ischemia vs NSTEMI. The patient has a complex medical history, including COPD, anemia, AFib with slow ventricular response, prolonged QTc, and a history of EtOH abuse.

The patient's current condition is as follows:

* Respiratory failure: The patient is intubated and mechanically ventilated due to hypoxemic respiratory failure.
* Cardiovascular: The patient has elevated troponin levels, suggesting acute myocardial injury, and is at risk for cardiac complications.
* Hemodynamic: The patient has hypotension, which is concerning for septic shock, and is receiving fluids and vasopressors as needed.
* Renal: The patient has hyponatremia, which may be due to volume loss or SIADH.
* Neurological: The patient is sedated and has a prolonged QTc, which may be due to medication side effects, ischemic heart disease, or hypocalcemia.

Potential medical complications that may arise include:

1. Cardiac complications: The patient's elevated troponin levels and risk factors for cardiac disease make cardiac complications, such as acute myocardial infarction or cardiac arrhythmias, a concern.
2. Respiratory failure: The patient's respiratory failure may worsen, leading to further complications such as respiratory acidosis or respiratory failure.
3. Septic shock: The patient's hypotension and elevated white blood cell count make septic shock a concern.
4. Renal failure: The patient's hyponatremia and potential volume loss may lead to renal failure.
5. Neurological complications: The patient's prolonged QTc and sedation may lead to neurological complications, such as seizures or cardiac arrest.
6. Infections: The patient's pneumonia and potential septic picture make infections, such as pneumonia or sepsis, a concern.
7. Gastrointestinal complications: The patient's history of EtOH abuse and potential gastrointestinal bleeding make gastrointestinal complications, such as gastrointestinal bleeding or pancreatitis, a concern.

The patient's current treatment plan includes:

* Antibiotics for pneumonia
* Vasopressors for hypotension
* Sedation for respiratory failure
* Fluid management for hyponatremia
* Cardiac medications for potential cardiac complications
* Consultations with dermatology and cardiology for further management

The patient's code status is full code, and his disposition is ICU."
140536.0,253109,2183-01-08 07:57:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   [**1-8**]
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient now on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean
   to FiO2 40%.
   [**1-7**]
   - a-line placed
   - antibiotics changed to cefepime and vancomycin for HCAP
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 400 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 07:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 36 (36 - 54) bpm
   BP: 109/58(74) {102/57(74) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 26 (14 - 26)mmHg
   Total In:
                                                                    638 mL
                                                                  1,333 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,333 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    355 mL
   Urine:
                                                                    125 mL
                                                                    355 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    978 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 1,022 (945 - 1,022) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 11
   PEEP: 0 cmH2O
   FiO2: 40%
   RSBI: 13
   PIP: 6 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 10.7 L/min
   PaO2 / FiO2: 415
   Physical Examination
   40%FiO2, Pressure Support
   GENERAL: Intubated.
   HEENT: NCAT. Sclera anicteric. Pupils 3mm->2mm reactive to light.  No
   xanthalesma.  Dry MM without visible lesions on tongue/lips.
   NECK: Supple without visible JVP.
   CARDIAC: PMI not palpated. Slow rate normal S1, S2. No m/r/g. No
   thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Coarse breath
   sounds bilaterally at anterior and lateral axillary fields. ABDOMEN:
   Soft, ND. Abd aorta not enlarged by palpation. Normal BS.  No
   abdominial bruits.
   EXTREMITIES: No clubbing, cyanosis, edema.  Warm [**Name Prefix (Prefixes) **] [**Last Name (Prefixes) **]/l.
   SKIN: Skin demonstrates diffuse/coalescing maculopapular erythematous
   rash with plaques/erosions on extremities and torso.
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72yo M p/w +biomarkers in the setting of LLL PNA due to demand ischemia
   vs NSTEMI.  Hypovolemia vs septic picture.
   .
   # Respiratory distress [**12-31**] PNA, lung disease.  LLL PNA at OSH.  Given
   recent hospitalization in [**October 2182**] we will give
   vancomycin/cefepime/azithromycin instead of azithromycin/ceftriaxone he
   received at OSH for HCAP.  LFTs nml at OSH.
   -Vanc/Cefepime, Vanc trough after 3 doses.
   -Continue azithromycin for atypical coverage.
   -CXR in AM
   -Continue intubation w/ fentanyl and midalozam.
   -Wean FiO2 as tolerated
   - f/u Sputum Cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with nebs (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   .
   FEN:  intubated, npo.
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with Heparin IV
   -Pain management with  morphine/ntg if needed once extubated (hold home
   neurontin 100mg TID home dose for now)
   -Bowel regimen with  docusate/senna
   -GI PPX: famotidine while NPO
   .
   CODE: Presumed full per OSH report
   .
   COMM: [**Name (NI) **]: [**Telephone/Fax (1) 13170**], [**Telephone/Fax (1) 13171**]
   .
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: IV heparin
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   [**1-8**]
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient now on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean
   to FiO2 40%.
   [**1-7**]
   - a-line placed
   - antibiotics changed to cefepime and vancomycin for HCAP
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 400 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 07:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 36 (36 - 54) bpm
   BP: 109/58(74) {102/57(74) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 26 (14 - 26)mmHg
   Total In:
                                                                    638 mL
                                                                  1,333 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,333 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    355 mL
   Urine:
                                                                    125 mL
                                                                    355 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    978 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 1,022 (945 - 1,022) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 11
   PEEP: 0 cmH2O
   FiO2: 40%
   RSBI: 13
   PIP: 6 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 10.7 L/min
   PaO2 / FiO2: 415
   Physical Examination
   40%FiO2, Pressure Support
   GENERAL: Intubated.
   HEENT: NCAT. Sclera anicteric. Pupils 3mm->2mm reactive to light.  No
   xanthalesma.  Dry MM without visible lesions on tongue/lips.
   NECK: Supple without visible JVP.
   CARDIAC: PMI not palpated. Slow rate normal S1, S2. No m/r/g. No
   thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Coarse breath
   sounds bilaterally at anterior and lateral axillary fields. ABDOMEN:
   Soft, ND. Abd aorta not enlarged by palpation. Normal BS.  No
   abdominial bruits.
   EXTREMITIES: No clubbing, cyanosis, edema.  Warm [**Name Prefix (Prefixes) **] [**Last Name (Prefixes) **]/l.
   SKIN: Skin demonstrates diffuse/coalescing maculopapular erythematous
   rash with plaques/erosions on extremities and torso.
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72yo M p/w +biomarkers in the setting of LLL PNA due to demand ischemia
   vs NSTEMI.  Hypovolemia vs septic picture.
   .
   # Respiratory distress [**12-31**] PNA, lung disease.  LLL PNA at OSH.  Given
   recent hospitalization in [**October 2182**] we will give
   vancomycin/cefepime/azithromycin instead of azithromycin/ceftriaxone he
   received at OSH for HCAP.  LFTs nml at OSH.
   -Vanc/Cefepime, Vanc trough after 3 doses.
   -Continue azithromycin for atypical coverage.
   -CXR in AM
   -Continue intubation w/ fentanyl and midalozam.
   -Wean FiO2 as tolerated
   - f/u Sputum Cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with nebs (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   .
   FEN:  intubated, npo.
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with Heparin IV
   -Pain management with  morphine/ntg if needed once extubated (hold home
   neurontin 100mg TID home dose for now)
   -Bowel regimen with  docusate/senna
   -GI PPX: famotidine while NPO
   .
   CODE: Presumed full per OSH report
   .
   COMM: [**Name (NI) **]: [**Telephone/Fax (1) 13170**], [**Telephone/Fax (1) 13171**]
   .
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: IV heparin
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 72-year-old male admitted to the ICU with a chief complaint of respiratory distress and hypovolemia. He has a history of chronic obstructive pulmonary disease (COPD), atrial fibrillation, and hypertension. He was previously hospitalized in October 2022 for pneumonia and was treated with antibiotics. He has a new wall motion abnormality and elevated troponin levels, suggesting demand ischemia or non-ST elevation myocardial infarction (NSTEMI).

The patient is currently intubated and receiving mechanical ventilation. He has a rash on his extremities and torso, which is suspected to be a drug reaction to lisinopril. He also has hyponatremia, hypotension, and hyperglycemia.

The patient's laboratory results show elevated troponin levels, mildly elevated CK-MB, and normal LFTs. His WBC count is elevated, and his platelet count is decreased.

The patient's plan includes:

* Weaning off mechanical ventilation and oxygen therapy as tolerated
* Continuing antibiotics and antiviral therapy for pneumonia
* Treating demand ischemia or NSTEMI with medication and close monitoring
* Managing hyperglycemia with insulin
* Managing hyponatremia with normal saline
* Managing hypotension with fluid resuscitation and vasopressors as needed
* Monitoring for signs of sepsis and adjusting treatment accordingly
* Consulting dermatology for further evaluation of the rash

Potential medical complications:

* Sepsis or septic shock due to pneumonia
* Cardiac complications, such as myocardial infarction or heart failure, due to demand ischemia or NSTEMI
* Respiratory failure or arrest due to pneumonia or mechanical ventilation
* Neurological complications, such as stroke or seizures, due to atrial fibrillation or sepsis
* Gastrointestinal complications, such as bleeding or perforation, due to stress ulcer or VAP
* Skin complications, such as toxic epidermal necrosis or drug-induced lupus erythematosis, due to the rash."
140536.0,253109,2183-01-08 07:57:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   [**1-8**]
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient now on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean
   to FiO2 40%.
   [**1-7**]
   - a-line placed
   - antibiotics changed to cefepime and vancomycin for HCAP
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 400 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 07:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 36 (36 - 54) bpm
   BP: 109/58(74) {102/57(74) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 26 (14 - 26)mmHg
   Total In:
                                                                    638 mL
                                                                  1,333 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,333 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    355 mL
   Urine:
                                                                    125 mL
                                                                    355 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    978 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 1,022 (945 - 1,022) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 11
   PEEP: 0 cmH2O
   FiO2: 40%
   RSBI: 13
   PIP: 6 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 10.7 L/min
   PaO2 / FiO2: 415
   Physical Examination
   40%FiO2, CPAP
   GENERAL: Intubated.
   HEENT: NCAT. Sclera anicteric. Pupils 3mm->2mm reactive to light.  No
   xanthalesma.  Dry MM without visible lesions on tongue/lips.
   NECK: Supple without visible JVP.
   CARDIAC: PMI not palpated. Slow rate normal S1, S2. No m/r/g. No
   thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Coarse breath
   sounds bilaterally at anterior and lateral axillary fields. ABDOMEN:
   Soft, ND. Abd aorta not enlarged by palpation. Normal BS.  No
   abdominial bruits.
   EXTREMITIES: No clubbing, cyanosis, edema.  Warm [**Name Prefix (Prefixes) **] [**Last Name (Prefixes) **]/l.
   SKIN: Skin demonstrates diffuse/coalescing maculopapular erythematous
   rash with plaques/erosions on extremities and torso.
   PULSES:  Weak 1 DP pules, 2 radial pulses b/l.
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72yo M p/w +biomarkers in the setting of LLL PNA due to demand ischemia
   vs NSTEMI.  Hypovolemia vs septic picture.
   .
   # Respiratory distress [**12-31**] PNA, lung disease.  LLL PNA at OSH.  Given
   recent hospitalization in [**October 2182**] we will give vancomycin/cefepime
   instead of azithromycin/ceftriaxone he received at OSH for HCAP.  LFTs
   nml at OSH.
   -Vanc/Cefepime, Vanc trough after 3 doses
   -CXR in AM
   -Continue intubation w/ fentanyl and midalozam.
   -Wean FiO2 as tolerated
   - f/u Sputum Cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with nebs (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   .
   FEN:  intubated, npo.
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with Heparin IV
   -Pain management with  morphine/ntg if needed once extubated (hold home
   neurontin 100mg TID home dose for now)
   -Bowel regimen with  docusate/senna
   -GI PPX: famotidine while NPO
   .
   CODE: Presumed full per OSH report
   .
   COMM: [**Name (NI) **]: [**Telephone/Fax (1) 13170**], [**Telephone/Fax (1) 13171**]
   .
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   [**1-8**]
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient now on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean
   to FiO2 40%.
   [**1-7**]
   - a-line placed
   - antibiotics changed to cefepime and vancomycin for HCAP
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 400 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 07:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 36 (36 - 54) bpm
   BP: 109/58(74) {102/57(74) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 26 (14 - 26)mmHg
   Total In:
                                                                    638 mL
                                                                  1,333 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,333 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    355 mL
   Urine:
                                                                    125 mL
                                                                    355 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    978 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 1,022 (945 - 1,022) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 11
   PEEP: 0 cmH2O
   FiO2: 40%
   RSBI: 13
   PIP: 6 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 10.7 L/min
   PaO2 / FiO2: 415
   Physical Examination
   40%FiO2, CPAP
   GENERAL: Intubated.
   HEENT: NCAT. Sclera anicteric. Pupils 3mm->2mm reactive to light.  No
   xanthalesma.  Dry MM without visible lesions on tongue/lips.
   NECK: Supple without visible JVP.
   CARDIAC: PMI not palpated. Slow rate normal S1, S2. No m/r/g. No
   thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Coarse breath
   sounds bilaterally at anterior and lateral axillary fields. ABDOMEN:
   Soft, ND. Abd aorta not enlarged by palpation. Normal BS.  No
   abdominial bruits.
   EXTREMITIES: No clubbing, cyanosis, edema.  Warm [**Name Prefix (Prefixes) **] [**Last Name (Prefixes) **]/l.
   SKIN: Skin demonstrates diffuse/coalescing maculopapular erythematous
   rash with plaques/erosions on extremities and torso.
   PULSES:  Weak 1 DP pules, 2 radial pulses b/l.
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72yo M p/w +biomarkers in the setting of LLL PNA due to demand ischemia
   vs NSTEMI.  Hypovolemia vs septic picture.
   .
   # Respiratory distress [**12-31**] PNA, lung disease.  LLL PNA at OSH.  Given
   recent hospitalization in [**October 2182**] we will give vancomycin/cefepime
   instead of azithromycin/ceftriaxone he received at OSH for HCAP.  LFTs
   nml at OSH.
   -Vanc/Cefepime, Vanc trough after 3 doses
   -CXR in AM
   -Continue intubation w/ fentanyl and midalozam.
   -Wean FiO2 as tolerated
   - f/u Sputum Cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with nebs (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   .
   FEN:  intubated, npo.
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with Heparin IV
   -Pain management with  morphine/ntg if needed once extubated (hold home
   neurontin 100mg TID home dose for now)
   -Bowel regimen with  docusate/senna
   -GI PPX: famotidine while NPO
   .
   CODE: Presumed full per OSH report
   .
   COMM: [**Name (NI) **]: [**Telephone/Fax (1) 13170**], [**Telephone/Fax (1) 13171**]
   .
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, here is a summary of the information and potential medical complications that can arise:

**Summary:**

The patient is a 72-year-old male who was admitted to the ICU with a diagnosis of pneumonia, atrial fibrillation, and possible septic shock. He has a history of chronic lung disease, hypertension, and ethanol abuse. The patient is intubated and receiving mechanical ventilation, and his vital signs are stable. He has a troponin level of 0.33, indicating possible myocardial injury. The patient's rash has been present for three months and is suspected to be a drug reaction.

**Potential Medical Complications:**

1. **Pneumonia:** The patient's pneumonia may worsen, leading to respiratory failure, septic shock, or death.
2. **Septic Shock:** The patient's septic shock may progress, leading to organ dysfunction, failure, or death.
3. **Myocardial Infarction:** The patient's elevated troponin level and possible wall motion abnormality suggest the possibility of myocardial infarction, which may lead to cardiac arrest, heart failure, or death.
4. **Rash:** The patient's rash may worsen, leading to skin damage, infection, or allergic reactions.
5. **Hypovolemia:** The patient's hypovolemia may worsen, leading to shock, organ dysfunction, or failure.
6. **Hypocalcemia:** The patient's hypocalcemia may worsen, leading to muscle cramps, seizures, or cardiac arrhythmias.
7. **Hyponatremia:** The patient's hyponatremia may worsen, leading to seizures, coma, or death.
8. **Glycemic Control:** The patient's hyperglycemia may worsen, leading to diabetic ketoacidosis, hyperosmolar nonketotic coma, or death.
9. **Cardiac Arrhythmias:** The patient's atrial fibrillation may worsen, leading to cardiac arrest, heart failure, or stroke.
10. **Pulmonary Embolism:** The patient's DVT prophylaxis may not be effective, leading to pulmonary embolism, which may be fatal.

**Plan:**

1. Continue to monitor the patient's vital signs, laboratory results, and medical condition.
2. Optimize the patient's respiratory and cardiovascular support.
3. Manage the patient's pain, nausea, and vomiting.
4. Monitor the patient's glycemic control and adjust insulin therapy as needed.
5. Consider consulting with a dermatologist to further evaluate the patient's rash and potential allergic reactions.
6. Monitor the patient's electrolyte levels and adjust fluid therapy as needed.
7. Consider consulting with a cardiologist to further evaluate the patient's myocardial injury and potential cardiac arrhythmias."
140536.0,253109,2183-01-09 07:15:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: Pneumonia, demand ischemia
   24 Hour Events:
   - Patient pain free and somnolent this AM.  Describe prior SOB and
   ?chest discomfort beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable.
   [**1-8**]
   - Derm consulted. Said Drug Induced Lupus may persist for days/weeks
   following discontinuation.  Wanted anti-histone antibody, which was
   done at [**Location (un) 250**], found to be negative (<1.0) [**2183-1-1**] 1024.
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean to
   FiO2 40% -->  EXTUBATED at 9am
   - Added back Azithro for atypical coverage PNA, and sent for VZV in
   sputum
   - still sleepy ~2pm ; ABG 7.35/39/79 looks fine
   - urine output ~2pm ~20cc/hr
   - Flu swab negative ; DC flu precautions
   - legionella urinary antigen negative.
   Allergies:
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-8**] 09:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-9**] 07:14 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.8
   HR: 51 (42 - 60) bpm
   BP: 139/63(88) {118/54(5) - 142/71(94)} mmHg
   RR: 11 (9 - 13) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 10 (8 - 287)mmHg
   Total In:
                                                                  2,342 mL
                                                                    106 mL
   PO:
                                                                     60 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  2,282 mL
                                                                     46 mL
   Blood products:
   Total out:
                                                                    930 mL
                                                                    310 mL
   Urine:
                                                                    930 mL
                                                                    310 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,412 mL
                                                                   -204 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   Ventilator mode: Standby
   Vt (Spontaneous): 941 (941 - 1,022) mL
   PS : 5 cmH2O
   RR (Spontaneous): 0
   PEEP: 0 cmH2O
   FiO2: 35%
   RSBI: 10
   PIP: 0 cmH2O
   SpO2: 99%
   ABG: 7.35/39/78.[**Numeric Identifier 181**]/22/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 226
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right DP pulse: Diminished), (Left DP pulse:
   Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles, Ronchi, L>R with mild positive egophony ),
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Skin:  Warm, Rash: diffuse scaling rash.
   Neurologic: sleepy but arousable, oriented x2.
   Labs / Radiology
   136 K/uL
   9.6 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   27.8 %
   7.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
   WBC
   3.2
   3.3
   7.1
   Hct
   28.8
   25.4
   27.8
   Plt
   136
   133
   136
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - discontinue vancomycin, switch back to ceftriaxone from cefepime
   because pseudomonas unlikely.  Continue azithromycin to cover atypical
   pathogens, although also less likely because of lobar consolidation.
   - f/u sputum cx
   - check EKG this AM.
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.
   -Heparin gtt, ASA
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   - Will plan for catheterization tomorrow for likely high grade stenotic
   but non-occlusive disease.
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - continue advair.
   .
   # Anemia: unclear etiology. Likely secondary to alcoholism.
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   - urine lytes
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg q4h per CIWA when extubated
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: heparin IV
   Stress ulcer: n/a
   VAP:  n/a
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: Pneumonia, demand ischemia
   24 Hour Events:
   - Patient pain free and somnolent this AM.  Describe prior SOB and
   ?chest discomfort beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable.
   [**1-8**]
   - Derm consulted. Said Drug Induced Lupus may persist for days/weeks
   following discontinuation.  Wanted anti-histone antibody, which was
   done at [**Location (un) 250**], found to be negative (<1.0) [**2183-1-1**] 1024.
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean to
   FiO2 40% -->  EXTUBATED at 9am
   - Added back Azithro for atypical coverage PNA, and sent for VZV in
   sputum
   - still sleepy ~2pm ; ABG 7.35/39/79 looks fine
   - urine output ~2pm ~20cc/hr
   - Flu swab negative ; DC flu precautions
   - legionella urinary antigen negative.
   Allergies:
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-8**] 09:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-9**] 07:14 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.8
   HR: 51 (42 - 60) bpm
   BP: 139/63(88) {118/54(5) - 142/71(94)} mmHg
   RR: 11 (9 - 13) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 10 (8 - 287)mmHg
   Total In:
                                                                  2,342 mL
                                                                    106 mL
   PO:
                                                                     60 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  2,282 mL
                                                                     46 mL
   Blood products:
   Total out:
                                                                    930 mL
                                                                    310 mL
   Urine:
                                                                    930 mL
                                                                    310 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,412 mL
                                                                   -204 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   Ventilator mode: Standby
   Vt (Spontaneous): 941 (941 - 1,022) mL
   PS : 5 cmH2O
   RR (Spontaneous): 0
   PEEP: 0 cmH2O
   FiO2: 35%
   RSBI: 10
   PIP: 0 cmH2O
   SpO2: 99%
   ABG: 7.35/39/78.[**Numeric Identifier 181**]/22/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 226
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right DP pulse: Diminished), (Left DP pulse:
   Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles, Ronchi, L>R with mild positive egophony ),
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Skin:  Warm, Rash: diffuse scaling rash.
   Neurologic: sleepy but arousable, oriented x2.
   Labs / Radiology
   136 K/uL
   9.6 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   27.8 %
   7.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
   WBC
   3.2
   3.3
   7.1
   Hct
   28.8
   25.4
   27.8
   Plt
   136
   133
   136
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - discontinue vancomycin, switch back to ceftriaxone from cefepime
   because pseudomonas unlikely.  Continue azithromycin to cover atypical
   pathogens, although also less likely because of lobar consolidation.
   - f/u sputum cx
   - check EKG this AM.
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.
   -Heparin gtt, ASA
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   - Will plan for catheterization tomorrow for likely high grade stenotic
   but non-occlusive disease.
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - continue advair.
   .
   # Anemia: unclear etiology. Likely secondary to alcoholism.
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   - urine lytes
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg q4h per CIWA when extubated
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: heparin IV
   Stress ulcer: n/a
   VAP:  n/a
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 72-year-old male admitted to the ICU with pneumonia due to demand ischemia vs NSTEMI. He has a history of COPD, hypertension, and alcoholism.

The patient's current condition is as follows:

* Respiratory: He is on CPAP with a FiO2 of 35% and has a respiratory rate of 11 breaths per minute. His ABG shows a pH of 7.35, pCO2 of 39 mmHg, and pO2 of 78 mmHg.
* Cardiovascular: He has atrial fibrillation with a slow ventricular response, and his troponin level is elevated. He has a history of hypertension and is taking antihypertensive medications.
* Hemodynamic monitoring: His central venous pressure (CVP) is 10 mmHg, and his mean arterial pressure (MAP) is 139 mmHg.
* Laboratory results: His white blood cell count (WBC) is 3.2 x 10^9/L, and his creatinine level is 1.2 mg/dL. His troponin level is 0.33 ng/mL, and his CK-MB level is 10 ng/mL.
* Skin: He has a diffuse scaling rash, which is likely due to drug-induced lupus erythematosis.

Potential medical complications that may arise include:

1. Respiratory failure: The patient's respiratory status is unstable, and he may require intubation and mechanical ventilation.
2. Cardiac complications: The patient's troponin level is elevated, and he has a history of hypertension and atrial fibrillation. He may be at risk for cardiac complications such as myocardial infarction or cardiogenic shock.
3. Infection: The patient has pneumonia and may be at risk for secondary infections such as sepsis or septic shock.
4. Hypotension: The patient's blood pressure is low, and he may be at risk for hypotension or shock.
5. Hyponatremia: The patient's sodium level is low, and he may be at risk for hyponatremia or seizures.
6. Hyperglycemia: The patient's glucose level is elevated, and he may be at risk for hyperglycemic complications such as diabetic ketoacidosis or hyperosmolar nonketotic coma.
7. Skin complications: The patient's skin rash may worsen or become infected, leading to complications such as cellulitis or necrotizing fasciitis.
8. Gastrointestinal complications: The patient's pneumonia may lead to gastrointestinal complications such as nausea, vomiting, or diarrhea.
9. Neurological complications: The patient's pneumonia may lead to neurological complications such as seizures, stroke, or encephalopathy.

Based on the patient's condition, the following plan of care is recommended:

1. Continue to monitor the patient's respiratory status and adjust his oxygen therapy as needed.
2. Continue to manage the patient's hypertension and atrial fibrillation with medications.
3. Continue to treat the patient's pneumonia with antibiotics and consider adding atypical coverage.
4. Monitor the patient's troponin level and adjust his anticoagulation therapy as needed.
5. Monitor the patient's sodium level and adjust his fluid therapy as needed.
6. Monitor the patient's glucose level and adjust his insulin therapy as needed.
7. Monitor the patient's skin rash and adjust his treatment as needed.
8. Monitor the patient's gastrointestinal status and adjust his treatment as needed.
9. Monitor the patient's neurological status and adjust his treatment as needed.

In conclusion, the patient is a complex case with multiple medical complications. He requires close monitoring and management to prevent complications and improve his outcome."
140536.0,253109,2183-01-09 07:15:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - Patient pain free and somnolent this AM.  Describe prior SOB and
   ?chest discomfort beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable.
   [**1-8**]
   - Derm consulted. Said Drug Induced Lupus may persist for days/weeks
   following discontinuation.  Wanted anti-histone antibody, which was
   done at [**Location (un) 250**], found to be negative (<1.0) [**2183-1-1**] 1024.
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean to
   FiO2 40% -->  EXTUBATED at 9am
   - Added back Azithro for atypical coverage PNA, and sent for VZV in
   sputum
   - still sleepy ~2pm ; ABG 7.35/39/79 looks fine
   - urine output ~2pm ~20cc/hr
   - Flu swab negative ; DC flu precautions
   - legionella urinary antigen negative.
   Allergies:
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-8**] 09:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-9**] 07:14 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.8
   HR: 51 (42 - 60) bpm
   BP: 139/63(88) {118/54(5) - 142/71(94)} mmHg
   RR: 11 (9 - 13) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 10 (8 - 287)mmHg
   Total In:
                                                                  2,342 mL
                                                                    106 mL
   PO:
                                                                     60 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  2,282 mL
                                                                     46 mL
   Blood products:
   Total out:
                                                                    930 mL
                                                                    310 mL
   Urine:
                                                                    930 mL
                                                                    310 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,412 mL
                                                                   -204 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   Ventilator mode: Standby
   Vt (Spontaneous): 941 (941 - 1,022) mL
   PS : 5 cmH2O
   RR (Spontaneous): 0
   PEEP: 0 cmH2O
   FiO2: 35%
   RSBI: 10
   PIP: 0 cmH2O
   SpO2: 99%
   ABG: 7.35/39/78.[**Numeric Identifier 181**]/22/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 226
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   136 K/uL
   9.6 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   27.8 %
   7.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
   WBC
   3.2
   3.3
   7.1
   Hct
   28.8
   25.4
   27.8
   Plt
   136
   133
   136
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH. Differential includes viral pna and
   bacterial pna. Contribution from underlying lung disease.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - check EKG, consider readding azithro to cover atypicals
   - flu DFA
   - CXR in AM, f/u on final
   - consider urine legionella ag
   - RSBI today, consider extubation if doing well, stop fentanyl and
   midazolam this AM
   - wean vent settings
   - f/u sputum cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Anemia: unclear etiology. [**Month (only) 51**] be secondary to alcoholism, viral
   pathology, hemolysis
   - consider viral etiology
   - guaiac stool
   - consider HIV test
   - consider hemolysis labs and iron studies.
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   - urine lytes
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg q4h per CIWA when extubated
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - Patient pain free and somnolent this AM.  Describe prior SOB and
   ?chest discomfort beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable.
   [**1-8**]
   - Derm consulted. Said Drug Induced Lupus may persist for days/weeks
   following discontinuation.  Wanted anti-histone antibody, which was
   done at [**Location (un) 250**], found to be negative (<1.0) [**2183-1-1**] 1024.
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean to
   FiO2 40% -->  EXTUBATED at 9am
   - Added back Azithro for atypical coverage PNA, and sent for VZV in
   sputum
   - still sleepy ~2pm ; ABG 7.35/39/79 looks fine
   - urine output ~2pm ~20cc/hr
   - Flu swab negative ; DC flu precautions
   - legionella urinary antigen negative.
   Allergies:
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-8**] 09:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-9**] 07:14 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.8
   HR: 51 (42 - 60) bpm
   BP: 139/63(88) {118/54(5) - 142/71(94)} mmHg
   RR: 11 (9 - 13) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 10 (8 - 287)mmHg
   Total In:
                                                                  2,342 mL
                                                                    106 mL
   PO:
                                                                     60 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  2,282 mL
                                                                     46 mL
   Blood products:
   Total out:
                                                                    930 mL
                                                                    310 mL
   Urine:
                                                                    930 mL
                                                                    310 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,412 mL
                                                                   -204 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   Ventilator mode: Standby
   Vt (Spontaneous): 941 (941 - 1,022) mL
   PS : 5 cmH2O
   RR (Spontaneous): 0
   PEEP: 0 cmH2O
   FiO2: 35%
   RSBI: 10
   PIP: 0 cmH2O
   SpO2: 99%
   ABG: 7.35/39/78.[**Numeric Identifier 181**]/22/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 226
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   136 K/uL
   9.6 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   27.8 %
   7.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
   WBC
   3.2
   3.3
   7.1
   Hct
   28.8
   25.4
   27.8
   Plt
   136
   133
   136
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH. Differential includes viral pna and
   bacterial pna. Contribution from underlying lung disease.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - check EKG, consider readding azithro to cover atypicals
   - flu DFA
   - CXR in AM, f/u on final
   - consider urine legionella ag
   - RSBI today, consider extubation if doing well, stop fentanyl and
   midazolam this AM
   - wean vent settings
   - f/u sputum cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Anemia: unclear etiology. [**Month (only) 51**] be secondary to alcoholism, viral
   pathology, hemolysis
   - consider viral etiology
   - guaiac stool
   - consider HIV test
   - consider hemolysis labs and iron studies.
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   - urine lytes
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg q4h per CIWA when extubated
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, the patient is a 72-year-old male who has been admitted to the ICU with respiratory failure due to pneumonia, demand ischemia, and NSTEMI. The patient has a history of COPD, anemia, and hyperglycemia, and is currently being treated for sepsis and pneumonia.

The patient's laboratory results show elevated troponin and CK-MB levels, indicating possible acute myocardial injury. The patient's cardiac enzymes are being trended, and he is being treated with heparin, aspirin, and clopidogrel.

The patient has a prolonged QTc interval, which is being monitored, and he is at risk for stroke due to his CHADS2 score of 4. He is also at risk for hypotension and hyponatremia, which are being treated with fluids and electrolyte replacement.

The patient has a rash that has been present for three months, which is suspected to be a drug reaction to lisinopril. The patient's dermatologist has suggested amlodipine or lisinopril as possible culprits, and the patient is being treated with topical steroids and antihistamines.

The patient has a history of ethanol abuse and is being treated with thiamine and folic acid. He is also at risk for hyperglycemia, which is being treated with insulin.

The patient's physical examination shows a temperature of 36.8Â°C, blood pressure of 139/63 mmHg, and a heart rate of 51 beats per minute. His respiratory rate is 11 breaths per minute, and his oxygen saturation is 99%.

The patient's vital signs are stable, and he is being weaned off the ventilator. His respiratory support is being weaned, and he is being extubated.

The patient's laboratory results show a white blood cell count of 3.2, hemoglobin of 9.6 g/dL, and a platelet count of 136 x 10^9/L. His liver function tests are normal, and his kidney function tests are mildly elevated.

The patient's medical history includes a history of COPD, anemia, and hyperglycemia. He has a history of ethanol abuse and is at risk for stroke and hypotension.

The patient's medication list includes heparin, aspirin, clopidogrel, simvastatin, and lumigan. He is also receiving insulin, thiamine, and folic acid.

The patient's plan of care includes continued treatment for pneumonia, demand ischemia, and NSTEMI. He will continue to receive heparin, aspirin, and clopidogrel, and his cardiac enzymes will be trended. He will also receive insulin and electrolyte replacement as needed.

The patient's potential medical complications include:

* Respiratory failure
* Cardiac arrest
* Stroke
* Hypotension
* Hyponatremia
* Hyperglycemia
* Rhabdomyolysis
* Acute kidney injury
* Acute liver injury

The patient's potential surgical complications include:

* Endotracheal intubation
* Tracheostomy
* Central venous catheter placement
* Arterial line placement
* Surgical intervention for cardiac or pulmonary complications."
140536.0,253109,2183-01-10 07:27:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia vs NSTEMI.
   24 Hour Events:
   - Patient pain.  Describe prior SOB and ?chest discomfort
   beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable. Rash is intermittently painful/pruritic.
   -Derm f/u: DiffDx: systemic lupus (SLE) and sub-acute cutaneous lupus
   (SCLE).  B/C his anti-histone antibodies were negative and they are
   positive in about 95% of patients with drug-induced SLE, this is less
   likely.  Anti-histone is often not positive in SCLE.  Anti-Ro antibody
   looking for SCLE.
   - DCed Azithromycin b/c QTc>500
   - Speech and swallow says he'll be OK to eat normal foods after Cath;
   will get thin liquids and ground solids tonight and NPO p MN for cath
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-10**] 07:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 51 (43 - 58) bpm
   BP: 152/74(94) {129/49(69) - 152/78(94)} mmHg
   RR: 12 (10 - 18) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
             Total In:
                                                                    542 mL
                                                                    277 mL
   PO:
                                                                    360 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    182 mL
                                                                     37 mL
   Blood products:
   Total out:
                                                                  1,360 mL
                                                                    400 mL
   Urine:
                                                                  1,360 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -818 mL
                                                                   -123 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ////
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present), no left
   femoral bruit, ?R femoral bruit
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : bibasilar coarse breath sounds)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed, Rash: diffuse
   Neurologic: Attentive, Responds to: Not assessed, Oriented (to): x2
   ([**2183**]), Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - discontinue vancomycin, switch back to ceftriaxone from cefepime
   because pseudomonas unlikely.
   - d/c azithromycin - prolonged QT, atypicals less likely
   - f/u sputum cx
   - check EKG this AM
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.
   - Heparin gtt, ASA - until to cath lab
   - Clopidrogrel loading dose 300mg and then 75 mg QD
   - Simvastatin 80mg
   - CCath today
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   - trend chemistry
   - urine lytes
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
   #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
   #  Hyperglycemia
   - Insulin SS
   # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Heparin gtt)
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU - possibly to floor later today
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia vs NSTEMI.
   24 Hour Events:
   - Patient pain.  Describe prior SOB and ?chest discomfort
   beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable. Rash is intermittently painful/pruritic.
   -Derm f/u: DiffDx: systemic lupus (SLE) and sub-acute cutaneous lupus
   (SCLE).  B/C his anti-histone antibodies were negative and they are
   positive in about 95% of patients with drug-induced SLE, this is less
   likely.  Anti-histone is often not positive in SCLE.  Anti-Ro antibody
   looking for SCLE.
   - DCed Azithromycin b/c QTc>500
   - Speech and swallow says he'll be OK to eat normal foods after Cath;
   will get thin liquids and ground solids tonight and NPO p MN for cath
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-10**] 07:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 51 (43 - 58) bpm
   BP: 152/74(94) {129/49(69) - 152/78(94)} mmHg
   RR: 12 (10 - 18) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
             Total In:
                                                                    542 mL
                                                                    277 mL
   PO:
                                                                    360 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    182 mL
                                                                     37 mL
   Blood products:
   Total out:
                                                                  1,360 mL
                                                                    400 mL
   Urine:
                                                                  1,360 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -818 mL
                                                                   -123 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ////
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present), no left
   femoral bruit, ?R femoral bruit
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : bibasilar coarse breath sounds)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed, Rash: diffuse
   Neurologic: Attentive, Responds to: Not assessed, Oriented (to): x2
   ([**2183**]), Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - discontinue vancomycin, switch back to ceftriaxone from cefepime
   because pseudomonas unlikely.
   - d/c azithromycin - prolonged QT, atypicals less likely
   - f/u sputum cx
   - check EKG this AM
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.
   - Heparin gtt, ASA - until to cath lab
   - Clopidrogrel loading dose 300mg and then 75 mg QD
   - Simvastatin 80mg
   - CCath today
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   - trend chemistry
   - urine lytes
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
   #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
   #  Hyperglycemia
   - Insulin SS
   # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Heparin gtt)
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU - possibly to floor later today<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the progress note, the patient is a 72-year-old male with a chief complaint of pneumonia due to demand ischemia vs NSTEMI. The patient has a history of COPD, anemia, and alcoholism.

The patient's current condition is as follows:

* Respiratory: The patient is reported to be hypoxemic, with a diagnosis of pneumonia, likely community-acquired pneumonia (CAP), and underlying lung disease.
* Cardiovascular: The patient has elevated troponin levels, mildly elevated CK-MB, and a new wall motion abnormality, suggesting demand ischemia vs NSTEMI. The patient is being managed medically for now and is scheduled for a cardiac catheterization after his respiratory status stabilizes.
* Hematological: The patient has anemia, likely secondary to alcoholism.
* Gastrointestinal: The patient has hyperglycemia and is being managed with regular insulin sliding scale.
* Dermatological: The patient has a rash that began 3 months ago, which is suspected to be a drug reaction to lisinopril or amlodipine, possibly with toxic epidermal necrosis or lichen planus.

Potential medical complications that can arise include:

* Respiratory failure: The patient's pneumonia and underlying lung disease put him at risk for respiratory failure.
* Cardiac complications: The patient's demand ischemia vs NSTEMI may lead to cardiac complications such as arrhythmias, heart failure, or myocardial infarction.
* Hematological complications: The patient's anemia may worsen if not managed properly.
* Gastrointestinal complications: The patient's hyperglycemia may lead to gastrointestinal complications such as nausea, vomiting, or diarrhea.
* Dermatological complications: The patient's rash may worsen or spread if not managed properly.

The patient's medications include:

* Heparin gtt for prophylaxis against deep vein thrombosis
* ASA for antiplatelet therapy
* Clopidrogrel for antiplatelet therapy
* Simvastatin for lipid-lowering therapy
* Insulin SS for glycemic control
* Lumigan (Bimatoprost) for glaucoma

The patient's laboratory results include:

* WBC: 3.2, 3.3, 7.1, 6.1
* Hct: 28.8, 25.4, 27.8, 29.9
* Plt: 136, 133, 136, 152
* Cr: 1.2, 1.1, 1.0, 1.0
* TropT: 0.51, 0.33
* TCO2: 22, 23, 22, 22
* Glucose: 162, 142, 158, 136
* Other labs: PT / PTT / INR: 10.7/30.7/0.9, CK / CKMB / Troponin-T: 77/10/0.33, ALT / AST: 16/35, Alk Phos / T Bili: 58/0.3, Differential-Neuts: 82.2%, Lymph: 15.1%, Mono: 2.0%, Eos: 0.4%, Ca++: 8.0 mg/dL, Mg++: 2.4 mg/dL, PO4: 4.6 mg/dL

The patient's plan of care includes:

* Continuing treatment with MDI (ipatropium, albuterol) for COPD
* Trending daily for anemia
* Following EKG and telemetry for Afib with slow ventricular response
* Managing hyperglycemia with regular insulin sliding scale
* Monitoring for dermatological complications
* Continuing prophylaxis against deep vein thrombosis and stress ulcer
* Monitoring for VAP"
140536.0,253109,2183-01-10 07:27:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia vs NSTEMI.
   24 Hour Events:
   - Patient pain.  Describe prior SOB and ?chest discomfort
   beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable. Rash is intermittently painful/pruritic.
   -Derm f/u: DiffDx: systemic lupus (SLE) and sub-acute cutaneous lupus
   (SCLE).  B/C his anti-histone antibodies were negative and they are
   positive in about 95% of patients with drug-induced SLE, this is less
   likely.  Anti-histone is often not positive in SCLE.  Anti-Ro antibody
   looking for SCLE.
   - DCed Azithromycin b/c QTc>500
   - Speech and swallow says he'll be OK to eat normal foods after Cath;
   will get thin liquids and ground solids tonight and NPO p MN for cath
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-10**] 07:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 51 (43 - 58) bpm
   BP: 152/74(94) {129/49(69) - 152/78(94)} mmHg
   RR: 12 (10 - 18) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
             Total In:
                                                                    542 mL
                                                                    277 mL
   PO:
                                                                    360 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    182 mL
                                                                     37 mL
   Blood products:
   Total out:
                                                                  1,360 mL
                                                                    400 mL
   Urine:
                                                                  1,360 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -818 mL
                                                                   -123 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ////
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present), no left
   femoral bruit, ?R femoral bruit
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : bibasilar coarse breath sounds)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed, Rash: diffuse
   Neurologic: Attentive, Responds to: Not assessed, Oriented (to): x2
   ([**2183**]), Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - discontinue vancomycin, switch back to ceftriaxone from cefepime
   because pseudomonas unlikely.
   - d/c azithromycin - prolonged QT, atypicals less likely
   - f/u sputum cx
   - check EKG this AM
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.
   - Heparin gtt, ASA - until to cath lab
   - Clopidrogrel loading dose 300mg and then 75 mg QD
   - Simvastatin 80mg
   - CCath today
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   - trend chemistry
   - urine lytes
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
   #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
   #  Hyperglycemia
   - Insulin SS
   # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Heparin gtt)
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU - possibly to floor later today
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia vs NSTEMI.
   24 Hour Events:
   - Patient pain.  Describe prior SOB and ?chest discomfort
   beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable. Rash is intermittently painful/pruritic.
   -Derm f/u: DiffDx: systemic lupus (SLE) and sub-acute cutaneous lupus
   (SCLE).  B/C his anti-histone antibodies were negative and they are
   positive in about 95% of patients with drug-induced SLE, this is less
   likely.  Anti-histone is often not positive in SCLE.  Anti-Ro antibody
   looking for SCLE.
   - DCed Azithromycin b/c QTc>500
   - Speech and swallow says he'll be OK to eat normal foods after Cath;
   will get thin liquids and ground solids tonight and NPO p MN for cath
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-10**] 07:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 51 (43 - 58) bpm
   BP: 152/74(94) {129/49(69) - 152/78(94)} mmHg
   RR: 12 (10 - 18) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
             Total In:
                                                                    542 mL
                                                                    277 mL
   PO:
                                                                    360 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    182 mL
                                                                     37 mL
   Blood products:
   Total out:
                                                                  1,360 mL
                                                                    400 mL
   Urine:
                                                                  1,360 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -818 mL
                                                                   -123 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ////
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present), no left
   femoral bruit, ?R femoral bruit
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : bibasilar coarse breath sounds)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed, Rash: diffuse
   Neurologic: Attentive, Responds to: Not assessed, Oriented (to): x2
   ([**2183**]), Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - discontinue vancomycin, switch back to ceftriaxone from cefepime
   because pseudomonas unlikely.
   - d/c azithromycin - prolonged QT, atypicals less likely
   - f/u sputum cx
   - check EKG this AM
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.
   - Heparin gtt, ASA - until to cath lab
   - Clopidrogrel loading dose 300mg and then 75 mg QD
   - Simvastatin 80mg
   - CCath today
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   - trend chemistry
   - urine lytes
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
   #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
   #  Hyperglycemia
   - Insulin SS
   # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Heparin gtt)
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU - possibly to floor later today<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 72-year-old male who presents with positive biomarkers in the setting of pneumonia due to demand ischemia vs NSTEMI. He has a history of chronic conditions, including COPD, anemia, and Afib with slow ventricular response.

The patient's current condition is as follows:

* Respiratory failure: The patient is reportedly hypoxemic, and his pneumonia is likely to be lobar in nature.
* Demand ischemia vs NSTEMI: The patient has elevated troponin and mildly elevated CK-MB, indicating possible acute myocardial injury. He is being medically managed for now, and a cardiac catheterization is planned after his respiratory status stabilizes.
* Rash: The patient has a diffuse rash that has been present for three months, which is suspected to be a drug reaction to lisinopril or amlodipine. He has stopped taking both medications, and a dermatology consult has suggested a possible diagnosis of drug-induced lupus erythematosis.
* Hyponatremia: The patient's sodium levels are low, likely due to volume loss or SIADH given his lung process and stress.
* Hyperglycemia: The patient's glucose levels are elevated, and he is being treated with insulin sliding scale.
* Other conditions: The patient has a history of EtOH abuse, glaucoma, and is being treated for anemia, Afib, and COPD.

Potential medical complications that may arise include:

* Respiratory failure: The patient's pneumonia may worsen, leading to respiratory failure.
* Cardiac complications: The patient's demand ischemia vs NSTEMI may progress, leading to cardiac complications such as heart failure, arrhythmias, or even cardiac arrest.
* Infectious complications: The patient's pneumonia may lead to secondary infections, such as sepsis or pneumonia-related complications.
* Rash progression: The patient's rash may worsen or spread, leading to skin-related complications.
* Hyponatremia progression: The patient's hyponatremia may worsen, leading to seizures, coma, or even death.
* Hyperglycemia complications: The patient's hyperglycemia may lead to diabetic ketoacidosis, hyperosmolar nonketotic syndrome, or other complications.
* EtOH withdrawal: The patient's EtOH abuse may lead to withdrawal symptoms, such as seizures, tremors, or hallucinations.

Based on the patient's condition and potential complications, the following plan should be implemented:

* Continue to monitor the patient's respiratory status and adjust his treatment plan accordingly.
* Manage the patient's demand ischemia vs NSTEMI with medical therapy, and plan a cardiac catheterization after his respiratory status stabilizes.
* Continue to treat the patient's rash with triamcinolone 0.1% cream and monitor for progression.
* Monitor the patient's sodium levels and adjust his treatment plan accordingly to prevent hyponatremia progression.
* Continue to treat the patient's hyperglycemia with insulin sliding scale and monitor for complications.
* Consider EtOH withdrawal treatment if the patient's EtOH abuse is suspected to be contributing to his condition.
* Monitor the patient's other conditions, including COPD, anemia, and Afib, and adjust his treatment plan accordingly."
140536.0,253109,2183-01-11 05:27:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia.
   24 Hour Events:
   -Cath showed mid-distal anterolateral HK, 1vCAD: mid LAD calcified
   lesion. PTCA w/ cutting balloon, underexpansion. Rotablade w/ 1.5 burr.
   2.75x15mm BMS placed. Postdilated to >20 atm w/ 2.75 NC balloon. Good
   angio result. Right fem angioseal. LVEDP 15-20.
   -on Ntg after cath lab for elevated pressures - will wean aggressively
   -restarted heparin gtt until figure out what to do for atrial
   fibrillation
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Ceftriaxone - [**2183-1-10**] 08:01 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-11**] 05:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.5
C (97.7
   Tcurrent: 36
C (96.8
   HR: 48 (44 - 65) bpm
   BP: 141/64(85) {123/54(70) - 164/79(99)} mmHg
   RR: 15 (11 - 20) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
   Height: 70 Inch
             Total In:
                                                                  1,772 mL
                                                                    183 mL
   PO:
                                                                    700 mL
             TF:
   IVF:
                                                                  1,072 mL
                                                                    183 mL
   Blood products:
   Total out:
                                                                  1,335 mL
                                                                    235 mL
   Urine:
                                                                  1,335 mL
                                                                    235 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    437 mL
                                                                    -52 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   General Appearance: Overweight / Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), no murmurs, rubs or
   gallops, low JVD
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : diffuse)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Diffuse rash
   Neurologic: Attentive, AOx2
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   115 mg/dL
   0.9 mg/dL
   25 mEq/L
   4.2 mEq/L
   34 mg/dL
   106 mEq/L
   136 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   0.9
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   115
   Other labs: PT / PTT / INR:10.8/36.5/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.6 mg/dL, PO4:4.6 mg/dL
   Imaging: CCATH: Pending. per fellow Cath showed mid-distal
   anterolateral HK, 1vCAD: mid LAD calcified lesion. PTCA w/ cutting
   balloon, underexpansion. Rotablade w/ 1.5 burr. 2.75x15mm BMS placed.
   Postdilated to >20 atm w/ 2.75 NC balloon. Good angio result. Right fem
   angioseal. LVEDP 15-20.
   Microbiology: Blood cx pending
   Urine cx negative
   Respiratory cx normal flora, yeast
   Legionella negative
   DFA negative
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - d/c CTX, oral cefpodoxime x5days
   - follow up blood cultures
   - follow prolonged QT
   - trend WBC, T
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  The patient liklely has high grade
   LAD lesion given new WMA, but is not likely from acute plaque rupture.
   - ASA
   - d/c heparin gtt
   - Clopidrogrel
   - Simvastatin 80mg
   - PT consult
   # HTN: restart [**Last Name (un) **], hold metoprolol
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  hyponatremia: likely due to volume loss.  Would also consider SIADH
   given lung process/stress.
   - trend chemistry
   - urine lytes
    #  Rash has been for 3 months per OSH report. Consider drug reaction
   to lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
    #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
    #  Hyperglycemia
   - Insulin SS
    # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia.
   24 Hour Events:
   -Cath showed mid-distal anterolateral HK, 1vCAD: mid LAD calcified
   lesion. PTCA w/ cutting balloon, underexpansion. Rotablade w/ 1.5 burr.
   2.75x15mm BMS placed. Postdilated to >20 atm w/ 2.75 NC balloon. Good
   angio result. Right fem angioseal. LVEDP 15-20.
   -on Ntg after cath lab for elevated pressures - will wean aggressively
   -restarted heparin gtt until figure out what to do for atrial
   fibrillation
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Ceftriaxone - [**2183-1-10**] 08:01 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-11**] 05:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.5
C (97.7
   Tcurrent: 36
C (96.8
   HR: 48 (44 - 65) bpm
   BP: 141/64(85) {123/54(70) - 164/79(99)} mmHg
   RR: 15 (11 - 20) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
   Height: 70 Inch
             Total In:
                                                                  1,772 mL
                                                                    183 mL
   PO:
                                                                    700 mL
             TF:
   IVF:
                                                                  1,072 mL
                                                                    183 mL
   Blood products:
   Total out:
                                                                  1,335 mL
                                                                    235 mL
   Urine:
                                                                  1,335 mL
                                                                    235 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    437 mL
                                                                    -52 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   General Appearance: Overweight / Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), no murmurs, rubs or
   gallops, low JVD
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : diffuse)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Diffuse rash
   Neurologic: Attentive, AOx2
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   115 mg/dL
   0.9 mg/dL
   25 mEq/L
   4.2 mEq/L
   34 mg/dL
   106 mEq/L
   136 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   0.9
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   115
   Other labs: PT / PTT / INR:10.8/36.5/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.6 mg/dL, PO4:4.6 mg/dL
   Imaging: CCATH: Pending. per fellow Cath showed mid-distal
   anterolateral HK, 1vCAD: mid LAD calcified lesion. PTCA w/ cutting
   balloon, underexpansion. Rotablade w/ 1.5 burr. 2.75x15mm BMS placed.
   Postdilated to >20 atm w/ 2.75 NC balloon. Good angio result. Right fem
   angioseal. LVEDP 15-20.
   Microbiology: Blood cx pending
   Urine cx negative
   Respiratory cx normal flora, yeast
   Legionella negative
   DFA negative
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - d/c CTX, oral cefpodoxime x5days
   - follow up blood cultures
   - follow prolonged QT
   - trend WBC, T
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  The patient liklely has high grade
   LAD lesion given new WMA, but is not likely from acute plaque rupture.
   - ASA
   - d/c heparin gtt
   - Clopidrogrel
   - Simvastatin 80mg
   - PT consult
   # HTN: restart [**Last Name (un) **], hold metoprolol
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  hyponatremia: likely due to volume loss.  Would also consider SIADH
   given lung process/stress.
   - trend chemistry
   - urine lytes
    #  Rash has been for 3 months per OSH report. Consider drug reaction
   to lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
    #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
    #  Hyperglycemia
   - Insulin SS
    # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 72-year-old male who presented with positive biomarkers in the setting of pneumonia due to demand ischemia. He underwent a cardiac catheterization and percutaneous coronary intervention (PCI) with a good angiographic result. He is currently being treated for atrial fibrillation, hypertension, and chronic obstructive pulmonary disease (COPD). He has a history of anemia, likely secondary to alcoholism, and a rash that has been present for three months. He is also being treated for hyperglycemia and has a history of glaucoma.

Potential Medical Complications:

1. Respiratory Failure: The patient's pneumonia and underlying lung disease put him at risk for respiratory failure. His hypoxemic condition and recent hospitalization for pneumonia increase his risk for respiratory failure.
2. Demand Ischemia vs NSTEMI: The patient's new wall motion abnormality and high-grade LAD lesion may indicate acute myocardial injury. However, the etiology of the lesion is unclear, and the patient may have a high-grade LAD lesion due to demand ischemia or NSTEMI.
3. Atrial Fibrillation: The patient's atrial fibrillation with a slow ventricular response increases his risk for stroke and cardiac arrhythmias.
4. Hyponatremia: The patient's hyponatremia may be due to volume loss or SIADH given his lung process and stress.
5. Rash: The patient's rash may be due to a drug reaction to lisinopril or amlodipine, and further evaluation is needed to determine the cause.
6. Anemia: The patient's anemia may be due to his history of alcoholism, and further evaluation is needed to determine the cause.
7. Glaucoma: The patient's glaucoma may be managed with topical medications, and further evaluation is needed to determine the severity of the condition.
8. Hyperglycemia: The patient's hyperglycemia may be due to his underlying condition and medications, and further evaluation is needed to determine the cause.
9. Prolonged QTc: The patient's prolonged QTc may be due to medication side effects, ischemic heart disease, or hypocalcemia, and further evaluation is needed to determine the cause.
10. Code Status: The patient's code status is full code, which may be a concern given his multiple medical conditions and risk for cardiac arrest.

Overall, the patient is at risk for various medical complications, and further evaluation and management are needed to address these concerns."
140536.0,253109,2183-01-11 05:27:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia.
   24 Hour Events:
   -Cath showed mid-distal anterolateral HK, 1vCAD: mid LAD calcified
   lesion. PTCA w/ cutting balloon, underexpansion. Rotablade w/ 1.5 burr.
   2.75x15mm BMS placed. Postdilated to >20 atm w/ 2.75 NC balloon. Good
   angio result. Right fem angioseal. LVEDP 15-20.
   -on Ntg after cath lab for elevated pressures - will wean aggressively
   -restarted heparin gtt until figure out what to do for atrial
   fibrillation
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Ceftriaxone - [**2183-1-10**] 08:01 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-11**] 05:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.5
C (97.7
   Tcurrent: 36
C (96.8
   HR: 48 (44 - 65) bpm
   BP: 141/64(85) {123/54(70) - 164/79(99)} mmHg
   RR: 15 (11 - 20) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
   Height: 70 Inch
             Total In:
                                                                  1,772 mL
                                                                    183 mL
   PO:
                                                                    700 mL
             TF:
   IVF:
                                                                  1,072 mL
                                                                    183 mL
   Blood products:
   Total out:
                                                                  1,335 mL
                                                                    235 mL
   Urine:
                                                                  1,335 mL
                                                                    235 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    437 mL
                                                                    -52 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   General Appearance: Overweight / Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : basilar)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Not assessed, Movement: Not
   assessed, Tone: Not assessed
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   115 mg/dL
   0.9 mg/dL
   25 mEq/L
   4.2 mEq/L
   34 mg/dL
   106 mEq/L
   136 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   0.9
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   115
   Other labs: PT / PTT / INR:10.8/36.5/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.6 mg/dL, PO4:4.6 mg/dL
   Imaging: CCATH: Pending. per fellow Cath showed mid-distal
   anterolateral HK, 1vCAD: mid LAD calcified lesion. PTCA w/ cutting
   balloon, underexpansion. Rotablade w/ 1.5 burr. 2.75x15mm BMS placed.
   Postdilated to >20 atm w/ 2.75 NC balloon. Good angio result. Right fem
   angioseal. LVEDP 15-20.
   Microbiology: Blood cx pending
   Urine cx negative
   Respiratory cx normal flora, yeast
   Legionella negative
   DFA negative
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - continue CTX for now, consider d/c'ing - patient has been afebrile,
   oxygenation improved
   - follow up blood cultures
   - follow prolonged QT
   - trend WBC, T
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  The patient liklely has high grade
   LAD lesion given new WMA, but is not likely from acute plaque rupture.
   - Heparin gtt, ASA - until to cath lab
   - Clopidrogrel loading dose 300mg and then 75 mg QD
   - Simvastatin 80mg
   - CCath today
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   - trend chemistry
   - urine lytes
    #  Rash has been for 3 months per OSH report. Consider drug reaction
   to lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
    #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
    #  Hyperglycemia
   - Insulin SS
    # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia.
   24 Hour Events:
   -Cath showed mid-distal anterolateral HK, 1vCAD: mid LAD calcified
   lesion. PTCA w/ cutting balloon, underexpansion. Rotablade w/ 1.5 burr.
   2.75x15mm BMS placed. Postdilated to >20 atm w/ 2.75 NC balloon. Good
   angio result. Right fem angioseal. LVEDP 15-20.
   -on Ntg after cath lab for elevated pressures - will wean aggressively
   -restarted heparin gtt until figure out what to do for atrial
   fibrillation
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Ceftriaxone - [**2183-1-10**] 08:01 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-11**] 05:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.5
C (97.7
   Tcurrent: 36
C (96.8
   HR: 48 (44 - 65) bpm
   BP: 141/64(85) {123/54(70) - 164/79(99)} mmHg
   RR: 15 (11 - 20) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
   Height: 70 Inch
             Total In:
                                                                  1,772 mL
                                                                    183 mL
   PO:
                                                                    700 mL
             TF:
   IVF:
                                                                  1,072 mL
                                                                    183 mL
   Blood products:
   Total out:
                                                                  1,335 mL
                                                                    235 mL
   Urine:
                                                                  1,335 mL
                                                                    235 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    437 mL
                                                                    -52 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   General Appearance: Overweight / Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : basilar)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Not assessed, Movement: Not
   assessed, Tone: Not assessed
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   115 mg/dL
   0.9 mg/dL
   25 mEq/L
   4.2 mEq/L
   34 mg/dL
   106 mEq/L
   136 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   0.9
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   115
   Other labs: PT / PTT / INR:10.8/36.5/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.6 mg/dL, PO4:4.6 mg/dL
   Imaging: CCATH: Pending. per fellow Cath showed mid-distal
   anterolateral HK, 1vCAD: mid LAD calcified lesion. PTCA w/ cutting
   balloon, underexpansion. Rotablade w/ 1.5 burr. 2.75x15mm BMS placed.
   Postdilated to >20 atm w/ 2.75 NC balloon. Good angio result. Right fem
   angioseal. LVEDP 15-20.
   Microbiology: Blood cx pending
   Urine cx negative
   Respiratory cx normal flora, yeast
   Legionella negative
   DFA negative
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - continue CTX for now, consider d/c'ing - patient has been afebrile,
   oxygenation improved
   - follow up blood cultures
   - follow prolonged QT
   - trend WBC, T
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  The patient liklely has high grade
   LAD lesion given new WMA, but is not likely from acute plaque rupture.
   - Heparin gtt, ASA - until to cath lab
   - Clopidrogrel loading dose 300mg and then 75 mg QD
   - Simvastatin 80mg
   - CCath today
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   - trend chemistry
   - urine lytes
    #  Rash has been for 3 months per OSH report. Consider drug reaction
   to lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
    #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
    #  Hyperglycemia
   - Insulin SS
    # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 72-year-old male admitted to the ICU with biomarkers indicating demand ischemia in the setting of pneumonia. He has a history of hypertension, hyperlipidemia, and chronic obstructive pulmonary disease (COPD). He underwent a cardiac catheterization, which showed a mid-distal anterolateral high-grade lesion in the left anterior descending (LAD) artery. A percutaneous coronary intervention (PCI) was performed, and a 2.75x15mm bare metal stent (BMS) was placed. He is currently being treated with heparin, aspirin, clopidogrel, and simvastatin.

The patient's vital signs are stable, with a temperature of 36.5Â°C, heart rate of 48 beats per minute, and blood pressure of 141/64 mmHg. He is oxygen-dependent, with a SpO2 of 98% on nasal cannula. His respiratory status is stable, with a respiratory rate of 15 breaths per minute and a partial pressure of arterial oxygen (PaO2) of 25 mmHg.

The patient's laboratory results show elevated troponin-T levels, indicating cardiac injury. His white blood cell count (WBC) is elevated, and his hemoglobin (Hb) level is decreased. His electrolyte levels are abnormal, with hyponatremia and hypocalcemia.

Potential medical complications:

1. Respiratory failure: The patient's pneumonia and underlying lung disease may lead to respiratory failure.
2. Cardiac complications: The patient's demand ischemia and cardiac injury may lead to cardiac complications, such as arrhythmias or heart failure.
3. Renal failure: The patient's hyponatremia and hypocalcemia may lead to renal failure.
4. Infection: The patient's pneumonia and underlying lung disease may lead to infection.
5. Bleeding: The patient's heparin therapy may increase the risk of bleeding.
6. Gastrointestinal complications: The patient's stress ulcer prophylaxis may not be effective, leading to gastrointestinal bleeding or perforation.
7. Neurological complications: The patient's hyponatremia and hypocalcemia may lead to neurological complications, such as seizures or coma.
8. Skin complications: The patient's rash may worsen or become infected, leading to skin complications.
9. Endocrine complications: The patient's hyperglycemia may lead to endocrine complications, such as diabetic ketoacidosis.
10. Ophthalmic complications: The patient's glaucoma may lead to ophthalmic complications, such as vision loss or blindness.

Based on the patient's condition, it is essential to monitor his vital signs, laboratory results, and clinical status closely to identify potential complications and provide appropriate treatment."
